Edwards Lifesciences Corporation Common Stock vs SpaceX — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while SpaceX trades at $166.5 (market cap $2.27T). The key difference: SpaceX is far larger — about 45.9× Edwards Lifesciences Corporation Common Stock's market cap, and SpaceX is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | SPCX | |
|---|---|---|
Market Cap | $49.44B | $2.27T |
Volume | 3,508,027 | 76,951,787 |
Sector | Health | Industrials |
52-Week High | $95.18 | $202.09 |
52-Week Low | $72.65 | $108.27 |
Enterprise Value | $45.90B | $2.21T |
Typical Hold Time | — | 41 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →